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Abstract
Introduction: To produce robust evidence RCTs need to be rigorously conducted as poorly performed studies
introduce bias and can mislead clinicians and policy makers. Poor allocation concealment has the largest single
impact on bias in RCTs than other methodological aspects. Envelopes are frequently used as a method of allocation
concealment and can be associated with increased risk of bias. This paper aims to review envelope use in RCTs
published in 2017–2018 and create a guide as a reference for researchers when planning and publishing RCTs when
using envelopes as an allocation concealment method.
Methods: RCTs that used envelopes as a form of allocation concealment that were published in BMJ, JAMA, NEJM and
The Lancet in 2017 and 2018 were identified and methodological data on their envelope use extracted and authors were
contacted to ascertain reasons for using envelopes in their research.
Results: 338 RCTs were identified that were published in 2017 and 2018. 8% (n¼ 29) of the RCTs published used
envelopes as an allocation concealment method. 24.1% (n¼ 7) of studies reported envelope studies robustly with all
required methodological information stated to enable an assessment of quality. Budget was the most frequent reason
given for envelope use (41.7%).
Discussion: Only 24% of published RCTs, that used envelopes, contained robust methodological information to enable
the reader to judge whether the randomisation and allocation concealment method was adequate.
Conclusion: RCTs are not reporting envelope use well. RCTs using envelopes should be designed and reported clearly
ensuring all necessary methodological information is included.
Keywords
Validity, reliability, bias, evidence-based medicine, methods and methodology, planning the research, designing a rand-
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Introduction
Randomised Controlled Trials (RCTs) are considered
to be the gold standard in assessing the effectiveness of
interventions. To produce robust evidence RCTs need
to be rigorously conducted as poorly performed studies
introduce bias and can mislead clinicians and policy
makers. Probably the single design element associated
with biased findings in trials is poor or absent alloca-
tion concealment.1,2
Allocation concealment
Allocation concealment is defined as the method used
to conceal the randomisation sequence from all study
personnel until after the patient has been recruited into
the study. This stops the randomisation sequence being
subverted and the study having a high risk of bias. It
has been shown that having an inadequate allocation
concealment method can exaggerate the effect size by
41%.1,2 There are multiple ways that the randomisa-
tion sequence can be concealed, such as web-based or
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telephone systems. Traditionally, before web and tele-
phone systems were available envelopes were used. The
use of sealed envelopes as a method still lingers on as a
concealment method for a significant proportion of
RCTs. For instance, Yelland et al found in 2015 that
9% of RCTs employed sealed envelopes as a method of
concealment.3
Advantages and disadvantages of envelope use as a
method of allocation concealment
There are significant disadvantages to using envelopes
for allocation concealment. They can be opened in
advance for example,4 trans illumination can determine
the allocation5–8 such methods allow subversion of the
randomisation. On the other hand they are relatively
cheap and logistically practical in remote areas that are
internet or telephone free or in emergency medicine
situations.
In this paper we aim to describe the types of trials
that continue to use envelopes and the quality of the
envelope concealment used and to provide advice on
their safer usage.
Methods
RCTs published in BMJ, JAMA, NEJM and The
Lancet in 2017 and 2018 were identified. Two reviewers
extracted data from each paper on the randomisation
and allocation concealment methods. Those RCTs that
used envelopes to conceal the randomisation sequence
were identified.
Envelope concealment
We used the approach described by Doig and Simpson9
to define high quality envelope concealment. There are
three areas that were assessed as follows:
1. If the person who created the envelope was stated
Best practice for the use of envelopes in RCTs would
be that a randomisation sequence would be generated
and personal not involved in the RCT would create the
envelopes for the RCT.
2. Whether the envelopes had an additional security
measure.
Envelopes should have an additional security mea-
sure rather than just being closed and be opaque and
sequentially numbered. This order can then be checked
and anomalies will be identified if the randomisation
sequence has been violated. Other additional security
measures include the person who has created the
envelope signing the back of the envelope when
sealed so it is obvious if it has been tampered with.
Inserting foil and or carbon paper into the envelope
prevents trans-illumination and the carbon paper
allows an additional audit trail as the participants
name and date of recruitment can be written on the
envelope at the point of recruitment before the enve-
lope has been opened and the carbon paper prints this
information to the allocation insert. The envelopes
should be kept securely and not with the research
team who are responsible for recruiting participants
into the study.
3. If the person who opened the envelope (recruited
participants) was stated
The person who created the envelope should not be
the same person who recruits participants to prevent
the ordering of participants into one treatment arm or
another.
We identified these and other quality factors and
extracted them from each RCT that used envelopes:
the envelope description, whether who created the
envelope and who opened the envelope was stated.
We emailed each corresponding author of the RCTs
that used envelopes as an allocation concealment
method and inquired as to why they have chosen enve-
lopes as an allocation concealment method.
Results
A total of 338 RCTs were identified that were pub-
lished in 2017 and 2018. 7.5% of RCTs published in
2017 used envelopes and 9.5% in 2018. Combined,
8.6% (n¼ 29) of the RCTs published in 2017 and
2018 used envelopes as an allocation concealment
method. We emailed each author of the RCTs using
envelopes and received responses from 12 (41%) of
them. Figure 1 shows the flow of studies.
Table 1 shows the description from the paper of
each envelope trial with the necessary quality factors
and trial setting. 24.1% (n¼ 7) of studies that use enve-
lopes for allocation concealment, reported envelope use
robustly with all required methodological information
stated to enable an assessment of quality. 44.8%
(n¼ 13) reported who created the envelope, 44.8%
(n¼ 13) reported who opened the envelope and
62.1% (n¼ 18) reported the envelope description
adequately.
Table 2 shows the author stated reasons for enve-
lope use, it was found that the most frequent reason
given was budget (41.7%).
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Discussion
Envelope use is similar to 2015 where Yelland found, in
a similar group of journals, that 9% of RCTs used
envelopes as a form of allocation concealment [2].
Reasons for envelope use were all appropriate for the
trial design and setting that the research was being
conducted.
It was disappointing that only 24% of the published
RCTs in this sample contained robust methodological
information to enable the reader to judge the RCT as
adequate and low risk of bias when assessing the ran-
domisation and allocation concealment methods. This
therefore means that 76% of RCTs cannot enter
into systematic reviews with a low risk of bias, there
will be a higher level of uncertainty of the validity of
the systematic review. All resources used to perform
this research is wasted as the published report is
not clear.
Many envelopes were not described as having any
additional security measures. They were simply stated
as being ‘sealed’, they may have been sequentially num-
bered however this was not stated so it cannot be
assumed. Only one study (Boden – see Appendix 1
for a list of all included studies) stated that they used
very secure envelopes with the addition of foil to wrap
the allocation cards within the envelopes. Foil prevents
the trans-illumination of the envelopes and further pro-
tects an RCT from subversion.1,9 It has been found
that RCTs employing the use of envelopes without
additional security measures are associated with an
exaggerated effect size.10 Results from insecure enve-
lopes will be treated with caution by policy makers –
thus highlighting the important of using secure enve-
lopes and ensuring that if secure envelopes were used
the details are reported comprehensively to enable
policy makers to have confidence in the reported
Randomised Controlled Trials 
(RCTs) identified in JAMA, BMJ, 
The Lancet and NEJM across 
2017 and 2018:
2017 n= 160
2018 n = 178
RCTs that used envelopes for 
allocation concealment identified: 
2017 n = 12
2018 n = 17
Authors of RCTs using envelopes 






Adequate reporting on the 
use of envelopes in the 
RCT:
n = 7
Figure 1. Flow of trials through study.
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Table 1. Quality factors and setting reported in included RCTs.
Author Envelope description
Additional security meas-










Andrews Sealed opaque envelopes Non reported No No No Emergency department
Smits Closed, opaque envelopes Non reported No No No Hospital
Landoni sealed, opaque, sequen-
tially numbered
envelopes




Sequentially numbered By persons not involved in
the trial
No No Referral center for epi-
lepsy surgery in north-
ern India, New Delhi
Kulkarni sealed, opaque envelopes, Non reported no No – ‘opened in the pre-
operative holding area
just before the patient
entered the operating
room’
No Operating theatre in
Uganda




Study packs were kept
available from a locked
study box from which




No No A tertiary paediatric
emergency department
(Melbourne)
Patel sealed in sequential num-
bered opaque
envelopes





Sequential numbered No trained health assistants
based





Sequentially assigned Person independent of the
research team and who








of Anaesthesia and Pain
Management, Perth
Chan sealed opaque envelopes Non reported independent staff member
assigned the treatments




























sequentially numbered The envelopes were gen-
erated by staff at
Gynuity Health Projects





Sequentially numbered no no No Hospital - Neonates born
>34 weeks who had
suspected early-onset
sepsis in the first 72 h of




Sequential No Yes: trial pharmacist and
clinician







No No No Emergency departments
and general pediatric











lopes. Foil used to
wrap allocation
cards. Patient details
were marked on enve-












Non reported No No No Four community hospitals
in the Netherlands























































No Yes: surgeon No Three hospitals in Finland
Peterli sealed envelopes Non reported No No No Four bariatric centres in
Switzerland
Jabre sealed envelopes Non reported No – implied that it is not
the same person who
opened the envelope
No No 20 prehospital emergency
medical services
(EMS) centers: 15 in
France and 5 in
Belgium.





Yes: ‘a separate person
not involved in the
study’
Yes: study nurse Yes Six health care facilities in
northern Lesotho.












Fossat sealed, opaque, and num-
bered envelopes
sealed, opaque, and num-
bered envelopes
Yes: a clinical research
assistant
Yes: investigator Yes ICU (hospital) in France
Cooper Sealed opaque envelopes
and permuted variable
block sizes (2 and 4).
Sealed opaque envelopes
and permuted variable
block sizes (2 and 4).
No No No Patients both out-of-hos-


























Montaigne The code sequence was
computer generated
and kept in sealed
envelopes at a central
location by non-medical
staff not involved in the
study.
Non reported No Yes: staff cardiologists No Hospital in France









Yes: study coordinator Yes Fertility clinics in New
Zealand





the baseline phase, the
respective envelope
was opened. .
Non reported Not explicit but states
‘Randomisation was
done centrally at the
study coordinating
centre by staff who




No No Diabetes practices in
Germany
Blumberger The randomisation tables
were used by staff out-








Non reported Yes: staff outside the study
team
Yes: study staff No Three hospitals in
Germany























results. The use of foil with sequentially numbered
sealed opaque envelopes in the opinion of the authors
of this paper should be the gold standard way to set up
an envelope for use within an RCT.
One point of interest is there are two RCTs in this
sample that describe the same methodology from the
large scale RCT but are reporting different results.
Interestingly one study was deemed methodologically
robust (Patel) and one was not (Nadkarni) as they did
not report who created the envelope. This small omis-
sion has resulted in a study not being classed as having
robust methodology.
There are a variety of valid reasons why envelopes
are used within RCTs. We would urge researchers to
carefully consider their research budget and assess
whether they should allocate additional funds to
cover the cost of a more robust and secure random-
isation and allocation concealment method if their
research design allows. Envelopes are inexpensive but
if not executed and published robustly the entire
research cannot contribute meaningfully to the evi-
dence base.
After analysing the data gained in this research we
can see that there is still a two-fold issue with envelope
use. Envelopes are not being prepared in a rigorous
manner with additional security measures and they
are not reported in a transparent robust way ensuring
all methodological information is provided. There is
unclear information given to ascertain whether the
envelope had additional security measures and whether
the person creating the envelope is separate to the
person who opens the envelope at the point of
recruitment.
Future recommendations
Figure 2 shows the recommendation we have to the
following when performing research with envelopes as
an allocation concealment method.
It is also pertinent to discuss the evolving nature of
technology and allocation concealment methods. For
rapid randomisation envelopes are a sensible choice,
there are however apps being created that can rapidly
randomise participants. These are also a relatively inex-
pensive method of randomisation and allocation con-
cealment and may be used more widely in the future.
Even with the use of innovative technology methodol-
ogy will still need to be published thoroughly for meth-
odological quality judgements to be made.
Moving forward we would urge authors to plan
for and create secure envelopes when using enve-
lopes as a form of allocation concealment are the
only option for their RCT and to write their
research transparently to include all the methodolog-























































































































































































































































































































































































































Clark et al. 9
ensure that any RCT published that uses envelopes
as a form of allocation concealment should be
reported robustly.
Conclusions
Allocation concealment methods are one of the most
influential methodological factors on the validity of an
RCT. Envelopes can be used as a robust method of
allocation concealment. However, they are the most
insecure method associated with subverting an RCT.
If they are used within a research design they
should be created robustly and reported clearly
ensuring all necessary methodological information is
included.
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